K. Learmonth

Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716.

K. Blyth, P. Woll, J. Edwards, 2020, Lung cancer.

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

J. Conner, L. Braidwood, Alexander Graham, 2014, Journal of hepatocellular carcinoma.